Eli Lilly and Co. Settle Zyprexa Case
Links shared publicly online about this topic
Lilly wins reversal of class status on Zyprexa
health.yahoo.net — “A federal appeals court decertified a class of unions and insurers that accused Eli Lilly and Co of overpricing its Zyprexa anti-psychotic drug after misrepresenting its efficacy and side effects.” View full resource at health.yahoo.net
Most Recently Shared on September 11, 2010 at 1:40 am By:
Lilly wins reversal of class status on Zyprexa http://bit.ly/bYfD2S
Class-Action Status Denied in Lilly Zyprexa Case - NYTimes.com
nytimes.com — “A federal appeals court overturned a ruling that had granted class-action status in a case on Lilly's top-selling schizophrenia drug.” View full resource at nytimes.com
Most Recently Shared on September 11, 2010 at 5:30 am By:
Hisham Rana, MD Doctor and Physician
News: Class-action status denied in case against Eli Lilly & Co. for improper marketing of the drug Zyprexa http://nyti.ms/doq4pq - #health
Government Cracks Down On Drug Marketing
medicalnewstoday.com — “Recent crackdown on pharmaceutical companies suggests that drug marketing remains an issue with federal authorities.” View full resource at medicalnewstoday.com
Most Recently Shared on February 1, 2010 at 2:08 pm By:
Government Cracks Down On Drug Marketing http://mnt.to/3x2p #epilepsy
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Healthy Society
Health news, If I'd known I was going to live so long, I'd have taken better care of myself. , don't make the same mistake.
-
Hisham Rana, MD
I tweet mostly about medicine, politics, and tech. Please see the link for a disclaimer and other policies.
-
MNT Epilepsy News
The latest epilepsy news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
